GlassScriptPhysician profile
Joseph P Clancy
NPI 1710914080
$11,996.58
in general payments reported to CMS, 2019-2025
35 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,141 · 2020: $1,361 · 2021: $2,130 · 2022: $1,764 · 2023: $1,781 · 2024: $2,368 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,594 · Education: $6.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,594.18 |
| Education | $6.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,651.87 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,231.28 | 2020-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Amgen INC. | $745.99 | 2019-2025 | Otezla, Repatha, Evenity |
| Abbvie INC. | $725.58 | 2020-2024 | Ubrelvy, Synthroid |
| Janssen Pharmaceuticals, INC | $620.05 | 2019-2024 | Xarelto |
| Lilly USA, LLC | $530.11 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $513.73 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $363.76 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $316.63 | 2019-2025 | Ozempic, Rybelsus |
| Medtronic, INC. | $267.82 | 2024 | Closurefast, Venaseal |
| Radius Health, INC. | $262.61 | 2019-2025 | Tymlos |
| Corcept Therapeutics | $208.03 | 2023-2024 | Korlym |
| E.R. Squibb & Sons, L.L.C. | $148.22 | 2019-2024 | Eliquis |
| Teva Pharmaceuticals USA, INC. | $143.52 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $141.52 | 2019-2021 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Clancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.